Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis
- PMID: 25121491
- PMCID: PMC4133404
- DOI: 10.1371/journal.pntd.0003071
Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis
Abstract
Background: Plasmodium vivax is one of the major species of malaria infecting humans. Although emphasis on P. falciparum is appropriate, the burden of vivax malaria should be given due attention. This study aimed to synthesize the evidence on severe malaria in P. vivax infection compared with that in P. falciparum infection.
Methods/principal findings: We searched relevant studies in electronic databases. The main outcomes required for inclusion in the review were mortality, severe malaria (SM) and severe anaemia (SA). The methodological quality of the included studies was assessed using the Newcastle-Ottawa Scale. Overall, 26 studies were included. The main meta-analysis was restricted to the high quality studies. Eight studies (n = 27490) compared the incidence of SM between P. vivax infection and P. falciparum mono-infection; a comparable incidence was found in infants (OR: 0.45, 95% CI:0.04-5.68, I2:98%), under 5 year age group (OR: 2.06, 95% CI: 0.83-5.1, I2:83%), the 5-15 year-age group (OR: 0.6, 95% CI: 0.31-1.16, I2:81%) and adults (OR: 0.83, 95% CI: 0.67-1.03, I2:25%). Six studies reported the incidences of SA in P. vivax infection and P. falciparum mono-infection; a comparable incidence of SA was found among infants (OR: 3.47, 95%:0.64-18.94, I2: 92%), the 5-15 year-age group (OR:0.71, 95% CI: 0.06-8.57, I2:82%). This was significantly lower in adults (OR:0.75, 95% CI: 0.62-0.92, I2:0%). Five studies (n = 71079) compared the mortality rate between vivax malaria and falciparum malaria. A lower rate of mortality was found in infants with vivax malaria (OR:0.61, 95% CI:0.5-0.76, I2:0%), while this was comparable in the 5-15 year- age group (OR: 0.43, 95% CI:0.06-2.91, I2:84%) and the children of unspecified-age group (OR: 0.77, 95% CI:0.59-1.01, I2:0%).
Conclusion: Overall, the present analysis identified that the incidence of SM in patients infected with P. vivax was considerable, indicating that P. vivax is a major cause of SM. Awareness of the clinical manifestations of vivax malaria should prompt early detection. Subsequent treatment and monitoring of complications can be life-saving.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Severe thrombocytopaenia in patients with vivax malaria compared to falciparum malaria: a systematic review and meta-analysis.Infect Dis Poverty. 2018 Feb 9;7(1):10. doi: 10.1186/s40249-018-0392-9. Infect Dis Poverty. 2018. PMID: 29427995 Free PMC article. Review.
-
Clinical features of children hospitalized with malaria--a study from Bikaner, northwest India.Am J Trop Med Hyg. 2010 Nov;83(5):981-9. doi: 10.4269/ajtmh.2010.09-0633. Am J Trop Med Hyg. 2010. PMID: 21036824 Free PMC article.
-
Plasmodium vivax malaria admissions and risk of mortality in a tertiary-care children's hospital in North India.Paediatr Int Child Health. 2012 Aug;32(3):152-7. doi: 10.1179/2046905512Y.0000000012. Paediatr Int Child Health. 2012. PMID: 22824663
-
Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.Malar J. 2010 Apr 6;9:89. doi: 10.1186/1475-2875-9-89. Malar J. 2010. PMID: 20370920 Free PMC article.
-
Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria.J Vector Borne Dis. 2018 Jan-Mar;55(1):1-8. doi: 10.4103/0972-9062.234620. J Vector Borne Dis. 2018. PMID: 29916441 Free PMC article. Review.
Cited by
-
Contrasting epidemiology and genetic variation of Plasmodium vivax infecting Duffy-negative individuals across Africa.Int J Infect Dis. 2021 Jul;108:63-71. doi: 10.1016/j.ijid.2021.05.009. Epub 2021 May 12. Int J Infect Dis. 2021. PMID: 33991680 Free PMC article.
-
Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infections.PLoS Negl Trop Dis. 2015 Mar 17;9(3):e0003539. doi: 10.1371/journal.pntd.0003539. eCollection 2015 Mar. PLoS Negl Trop Dis. 2015. PMID: 25781890 Free PMC article.
-
Chronic hepatitis B virus infection drives changes in systemic immune activation profile in patients coinfected with Plasmodium vivax malaria.PLoS Negl Trop Dis. 2019 Jun 24;13(6):e0007535. doi: 10.1371/journal.pntd.0007535. eCollection 2019 Jun. PLoS Negl Trop Dis. 2019. PMID: 31233500 Free PMC article.
-
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.Drug Des Devel Ther. 2016 Jul 26;10:2387-99. doi: 10.2147/DDDT.S61443. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27528800 Free PMC article. Review.
-
Which diagnostic test to use for Testing and Treatment strategies in Plasmodium vivax low-transmission settings: a secondary analysis of a longitudinal interventional study.Lancet Reg Health Am. 2024 Sep 15;38:100883. doi: 10.1016/j.lana.2024.100883. eCollection 2024 Oct. Lancet Reg Health Am. 2024. PMID: 39319096 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources